Fortrea Announces Date for Second Quarter 2026 Financial Results and Conference Call
Rhea-AI Summary
Fortrea (Nasdaq: FTRE) will release its second quarter 2026 financial results before the market opens on Wednesday, July 29, 2026. The company will host a conference call at 8:00 a.m. ET that same day to discuss the results, with access via pre-registration for dial-in details and a unique PIN, and a live webcast and replay available at investors.fortrea.com.
Positive
- None.
Negative
- None.
News Market Reaction – FTRE
In the Jul 13 session, FTRE gained 0.56%, reflecting a mild positive market reaction. Argus tracked a trough of -9.2% from its starting point during tracking.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Conferences,earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 21 | Earnings date announcement | Neutral | -1.1% | Set timing and access details for Q1 2026 earnings release and call. |
| Jan 29 | Earnings date announcement | Neutral | +1.9% | Announced date and call information for Q4 and full-year 2025 results. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Earnings date announcements have historically produced small, mixed share reactions around the news date.
Key Terms
cro medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
DURHAM, N.C., July 13, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its second quarter 2026 financial results before the market opens on Wednesday, July 29, 2026. The Company will host a conference call at 8:00 a.m. ET on that day to discuss the results.
To participate in the conference call, participants should pre-register via the call registration link. All registrants will receive dial-in details and a unique PIN providing access to the live call. To avoid potential delays, participants are encouraged to join at least 10 minutes prior to the start of the call.
The live webcast can be accessed at investors.fortrea.com. A replay will be available in the Events and Presentations section of the site following the conclusion of the call.
About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to clients globally. Learn more about how Fortrea is streamlining drug development at Fortrea.com and follow us on LinkedIn, X and Bluesky.
Fortrea Contacts
Tracy Krumme (Investors) – 984-385-6707, tracy.krumme@fortrea.com
Sue Zaranek (Media) – 919-943-5422, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com
